Ann: DermaScan AI receives medical device approval, page-22

I totally agree .
but educate the people making the announcements.
price sensitive is revenue and future cases information
developments and deals and contracts without future generating revue be numbers or solid details are non price sensitive.
nothing wrong with announcements, but placing emphasis on price sensitivity without any details and growing a reputation for doing this keeps prospective investors out of the game which places and keeps downward pressure on SP .
simple supply and demand .
nothing wrong with demand and interest at all, but overplaying the hand with what could be considered good informative announcements once or max twice per month is good . 3 per week is just plain amateur hour .